Donanemab in Early Alzheimer's Disease.

•  
• Overview
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Mintun, Mark A
• Brys, Miroslaw
• Liana Apostolova, MD, MSc, FAAN
• Salloway, Stephen P
• Skovronsky, Daniel M
• Lo, Albert C
• Duggan Evans, Cynthia
• Wessels, Alette M
• Ardayfio, Paul A
• Andersen, Scott W
• Shcherbinin, Sergey
• Sparks, JonDavid
• Sims, John R

publication date

• January 1, 2021

published in

• The New England journal of medicine  Journal

has subject area

• Activities of Daily Living
• Administration, Intravenous
• Aged
• Alzheimer Disease
• Brain Edema
• Cognition
• Disease Progression
• Double-Blind Method
• Epitopes
• Female
• Humans
• Male
• Mental Status and Dementia Tests
• Plaque, Amyloid
• Pyrrolidonecarboxylic Acid
• Severity of Illness Index

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.1056/nejmoa2100708

PubMed ID

• 33720637

Additional Document Info

start page

• 1691

end page

• 1704

volume

• 384

issue

• 18